Phase 1 Trial for Primary Biliary Cholangitis Therapy Produces Promising Results
source: pixabay.com

Phase 1 Trial for Primary Biliary Cholangitis Therapy Produces Promising Results

Albireo Pharma Inc. has just announced the results from their Phase 1 clinical trial for A3907, an ASBT inhibitor. The study produced positive results, achieving its primary and secondary endpoints. Researchers…

Continue Reading Phase 1 Trial for Primary Biliary Cholangitis Therapy Produces Promising Results
Primary Sclerosing Cholangitis Can Do a Number on Your Liver
[Source: By Bobjgalindo (Own work) [GFDL (http://www.gnu.org/copyleft/fdl.html) or CC BY-SA 4.0-3.0-2.5-2.0-1.0 (http://creativecommons.org/licenses/by-sa/4.0-3.0-2.5-2.0-1.0)], via Wikimedia Commons]

Primary Sclerosing Cholangitis Can Do a Number on Your Liver

Primary sclerosing cholangitis, or PSC, is a chronic progressive disease that damages the bile ducts. And, if you didn't know, bile is a liquid that assists the body in the…

Continue Reading Primary Sclerosing Cholangitis Can Do a Number on Your Liver